Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2017 Oct 1;11(4):262-267.

Effect of Short Hydration on Cisplatin-Induced Nephrotoxicity in Cancer Patients: A Retrospective Study

Farzaneh Ashrafi  1   2 , Zeinab Ebrahimi  3 , Mehdi Nematbakhsh  4   5
Affiliations

Effect of Short Hydration on Cisplatin-Induced Nephrotoxicity in Cancer Patients: A Retrospective Study

Farzaneh Ashrafi et al. Int J Hematol Oncol Stem Cell Res. .

Abstract

Background: The aim of this study was to evaluate the protective role of short hydration against nephrotoxicity induced by cisplatin (CDDP). Materials and Methods: Twenty-two patients (13 men and 9 women) under CDDP therapy were enrolled in this retrospective study between 2009 and 2014. The CDDP was given in 500 ml of isotonic solution, and before and after CDDP administration, the patients received 10mEq potassium chloride15% and 1gr magnesium sulfate in 1000 ml isotonic saline. Renal parameters were evaluated on the first day of each cycle of CDDP therapy. Results: Median cumulative CDDP dose was 465 mg/m2. Based on renal parameters, the prevalence of CDDP-induced nephrotoxicity (CIN) was 22.7%, while no hypokalemia and hypomagnesemia were observed. Conclusion: Short hydration accompanied with potassium chloride and magnesium sulfate may decrease the risk of CIN.

Keywords: Cisplatin; Hydration; Magnesium; Nephrotoxicity; Potassium.

PubMed Disclaimer

References

    1. Hayati F, Hossainzadeh M, Shayanpour S, et al. Prevention of cisplatin nephrotoxicity. J Nephropharmacol. 2016;5(1):57–60. - PMC - PubMed
    1. Pabla N, Dong Z. Cisplatin nephrotoxicity: mechanisms and renoprotective strategies. Kidney Int. 2008;73(9):994–1007. - PubMed
    1. Antunes LM, Darin JD, Bianchi MD. Protective effects of vitamin C against cisplatin-induced nephrotoxicity and lipid peroxidation in adult rats: a dose-dependent study. Pharmacol Res. 2000;41(4):405–11. - PubMed
    1. Miller RP, Tadagavadi RK, Ramesh G, et al. Mechanisms of cisplatin nephrotoxicity. Toxins (Basel) 2010;2(11):2490–2518. - PMC - PubMed
    1. dos Santos NA, Carvalho Rodrigues MA, Martins NM. Cisplatin-induced nephrotoxicity and targets of nephroprotection: an update. Arch Toxicol. 2012;86(8):1233–50. - PubMed

LinkOut - more resources